| human | Q5 |
| P213 | ISNI | 0000000071970574 |
| P12541 | Ludzie Nauki ID (new) | uBXpH7FK8T6 |
| P1207 | NUKAT ID | n98024590 |
| P7293 | PLWABN ID | 9810646388005606 |
| P3124 | Polish scientist ID | 30603 |
| P4012 | Semantic Scholar author ID | 2936205 |
| P214 | VIAF ID | 101994241 |
| P512 | academic degree | habilitation | Q308678 |
| doctorate | Q849697 | ||
| scientific professorship degree | Q55695329 | ||
| P27 | country of citizenship | Poland | Q36 |
| P185 | doctoral student | Marcin Tutaj | Q116773563 |
| Agnieszka Słowik | Q30437288 | ||
| Miroslaw Brys | Q57102126 | ||
| Joanna Pera | Q57981485 | ||
| Paweł Kiper | Q82735370 | ||
| Elżbieta Mirek | Q86882675 | ||
| Aleksandra Klimkowicz-Mrowiec | Q87737398 | ||
| Magdalena Bosak | Q92648619 | ||
| Tomasz Bochenek | Q93354506 | ||
| Magdalena Wójcik-Pędziwiatr | Q95976617 | ||
| Rafał Motyl | Q114310839 | ||
| Barbara Tomik | Q114416365 | ||
| Wojciech Turaj | Q114448941 | ||
| Tomasz Iskra | Q116773557 | ||
| Lidia Głodzik-Sobańska | Q116773560 | ||
| P69 | educated at | Military Medical Academy | Q9377456 |
| P108 | employer | Jagiellonian University | Q189441 |
| Podhale State Higher Vocational School in Nowy Targ | Q11820361 | ||
| P734 | family name | Szczudlik | Q108629027 |
| Szczudlik | Q108629027 | ||
| Szczudlik | Q108629027 | ||
| P735 | given name | Stanisław | Q19801658 |
| Stanisław | Q19801658 | ||
| Andrzej | Q14941830 | ||
| Andrzej | Q14941830 | ||
| P1412 | languages spoken, written or signed | Polish | Q809 |
| P1559 | name in native language | Andrzej Szczudlik | |
| P103 | native language | Polish | Q809 |
| P106 | occupation | physician | Q39631 |
| researcher | Q1650915 | ||
| neurologist | Q783906 | ||
| P21 | sex or gender | male | Q6581097 |
| Q30437288 | Agnieszka Słowik |
| Q87737398 | Aleksandra Klimkowicz-Mrowiec |
| Q114416365 | Barbara Tomik |
| Q86882675 | Elżbieta Mirek |
| Q57981485 | Joanna Pera |
| Q116773560 | Lidia Głodzik-Sobańska |
| Q92648619 | Magdalena Bosak |
| Q95976617 | Magdalena Wójcik-Pędziwiatr |
| Q116773563 | Marcin Tutaj |
| Q57102126 | Miroslaw Brys |
| Q82735370 | Paweł Kiper |
| Q114310839 | Rafał Motyl |
| Q93354506 | Tomasz Bochenek |
| Q116773557 | Tomasz Iskra |
| Q114448941 | Wojciech Turaj |
| Q54000313 | -The evaluation of the effectiveness and tolerance of sumatriptan in abortive treatment of migraine attacks (open multicenter trial). |
| Q72726109 | 2 cases of congenital analgesia |
| Q50933737 | A case report of patient with cerebellar variant of stiff person syndrome. |
| Q47940558 | A comparison of emotional decoding abilities in patients with amnestic mild cognitive impairment, very mild and mild Alzheimer's disease |
| Q45766281 | A novel conserved mutation in SGCE gene in 3 unrelated patients with classical phenotype myoclonus-dystonia syndrome |
| Q50278416 | A phenotypic-genetic study of a group of Polish patients with spinal and bulbar muscular atrophy. |
| Q59632208 | A-G-4G haplotype ofPAI-1gene polymorphisms −844 G/A,HindIIIG/C, and −675 4G/5G is associated with increased risk of ischemic stroke caused by small vessel disease |
| Q51646191 | A1/A2 polymorphism of GpIIIa gene and a risk of aneurysmal subarachnoid haemorrhage. |
| Q47390992 | A2 alelle of GpIIIa gene is a risk factor for stroke caused by large-vessel disease in males |
| Q48403848 | ACE I/D polymorphism in different etiologies of ischemic stroke |
| Q80547471 | ACE genotype, risk and causal relationship to stroke: implications for treatment |
| Q48954042 | ALS-Plus syndrome. A clinical and neuropathological case study |
| Q74285637 | Activation of MAP kinase (ERK-1/ERK-2), tyrosine kinase and VEGF in the human brain following acute ischaemic stroke |
| Q72581212 | Acupuncture-induced changes in human plasma insulin level |
| Q50117314 | Alpha-2-antiplasmin Arg407Lys polymorphism and cryptogenic ischemic cerebrovascular events: Association with neurological deficit |
| Q39708092 | Alpha1-antichymotrypsin gene (SERPINA3) A/T polymorphism as a risk factor for aneurysmal subarachnoid hemorrhage |
| Q42525916 | An attempt at evaluating borderline conditions of Parkinson's disease and its preclinical stage on the basis of clinical and morphological correlation. |
| Q46946547 | Apomorphine in off state--clinical experience |
| Q46946567 | Are dopamine agonists alternative therapy for levodopa in early stage of Parkinson's disease? Yes |
| Q45173977 | Association between hyperglycemia, heart failure and mortality in stroke patients |
| Q48160443 | Asymmetrical modulation of interleukin-10 release in patients with intracerebral hemorrhage |
| Q72412016 | Beta endorphin-like immunoreactivity in the blood of patients with chronic pain treated by pinpoint receptor stimulation (acupuncture) |
| Q51484417 | Beta-blockers reduce the risk of early death in ischemic stroke. |
| Q47717960 | Beta-blockers use and risk of hyperglycemia in acute stroke patients |
| Q76375460 | Calpain 10 gene polymorphisms and the risk of ischaemic stroke in a Polish population |
| Q85003761 | Cardiac responses to orthostatic stress deteriorate in Parkinson disease patients who begin to fall |
| Q72741356 | Case of congenital pain insensitivity |
| Q54684910 | Causes and consequences of falls in Parkinson disease patients in a prospective study. |
| Q43854550 | Causes and risk factors of falls in patients with Parkinson's disease |
| Q48732676 | Cerebrotendinous xanthomatosis: a rare cause of spinocerebellar syndrome |
| Q62844764 | Clinical and genetic characteristics of late-onset Huntington's disease |
| Q50639007 | Clinical presentation of early-onset Alzheimer's disease as a result of mutation in exon 12 of the PSEN-1 gene. |
| Q44194185 | Coagulation factor XIII VaI34Leu polymorphism in patients with small vessel disease or primary intracerebral hemorrhage |
| Q44204133 | Cognitive impairment and cardiovascular disease risk factors. Project CASCADE Kraków. II. Agreement of Mini-Mental State Examination (MMSE) obtained by nurses and by psychologists from the same persons at age 67-78 years of age |
| Q44486878 | Cognitive impairment and cardiovascular disease risk factors. Project CASCADE Kraków. III. Assessment of cognitive function in elderly women and men (65-78 years old) |
| Q48223713 | Cognitive impairment in carriers of glucocerebrosidase gene mutation in Parkinson disease patients |
| Q38818983 | Computational models and motor learning paradigms: Could they provide insights for neuroplasticity after stroke? An overview. |
| Q80385008 | DD genotype of ACE gene is a risk factor for intracerebral hemorrhage |
| Q44896469 | Daily excretion of epinephrine and norepinephrine in acute phase of cerebral ischemia |
| Q55467785 | Decreased levels of interleukin-10 and transforming growth factor-beta 2 in cerebrospinal fluid of patients with high grade astrocytoma. |
| Q39201921 | Deep brain stimulation in the treatment of Holmes tremor - a long-term case observation |
| Q36140500 | Depressogenic medications and other risk factors for depression among Polish patients with epilepsy |
| Q50755203 | Determination of nitrite/nitrate in human biological material by the simple Griess reaction. |
| Q53257572 | Dexamethasone inhibits TNF-alpha synthesis more effectively in Alzheimer's disease patients than in healthy individuals. |
| Q70109847 | Dexamethasone suppresses cortisol but not ACTH and beta-endorphin plasma concentration in healthy man |
| Q38284315 | Diagnosis and management of neuropathic pain: review of literature and recommendations of the Polish Association for the Study of Pain and the Polish Neurological Society - Part Two. |
| Q38244296 | Diagnosis and management of neuropathic pain: review of literature and recommendations of the Polish Association for the study of pain and the Polish Neurological Society - part one. |
| Q43469439 | Difficulties in establishing the etiology of ciliary ganglion lesions |
| Q48806723 | Does apoptosis occur in amyotrophic lateral sclerosis? TUNEL experience from human amyotrophic lateral sclerosis (ALS) tissues. |
| Q51088045 | Dynamic cerebral autoregulation is compromised in ischaemic stroke of undetermined aetiology only in the non-affected hemisphere. |
| Q44457436 | Emotional decoding abilities do not influence behavioral disturbances in Alzheimer's disease |
| Q53860715 | Endoglin gene insertion polymorphism not associated with aneurysmal subarachnoid hemorrhage. |
| Q43634357 | Etiopathogenesis of diabetic neuropathy |
| Q73627458 | Evaluation of dysarthria with the assistance of acoustic speech analysis in patients with amyotrophic lateral sclerosis |
| Q46832967 | Evaluation of polyneuropathy severity in chronic renal failure patients on continuous ambulatory peritoneal dialysis or on maintenance hemodialysis |
| Q51978047 | Evoked cardiac response components in cognitive processing: differential effects of amyotrophic lateral sclerosis. |
| Q37602879 | Eye movement abnormalities in essential tremor. |
| Q50239833 | Eye movements in essential tremor patients with parkinsonian and cerebellar signs. |
| Q47771540 | Factors affecting the quality of life in hemifacial spasm patients |
| Q51940523 | Factors associated with pre-stroke dementia: the cracow stroke database. |
| Q40405985 | Factors related to the occurrence of hyperthermia in patients with acute ischaemic stroke and with primary intracerebral haemorrhage |
| Q51896940 | Falls in different types of Parkinson's disease. |
| Q59632202 | Fibrin clot properties in acute ischemic stroke: relation to neurological deficit |
| Q46990969 | GABA in ischemic stroke. Proton magnetic resonance study. |
| Q51555935 | Gastric electromechanical dysfunction in Parkinson's disease. |
| Q48792283 | Gender-related differences in diagnostic evaluation and outcome of ischemic stroke in Poland |
| Q38507815 | Gene expression profiles in human ruptured and unruptured intracranial aneurysms: what is the role of inflammation? |
| Q36994302 | Gene expression profiling of blood in ruptured intracranial aneurysms: in search of biomarkers |
| Q46640591 | Glutathione peroxidase 1 C593T polymorphism is associated with lobar intracerebral hemorrhage |
| Q50437990 | Hemifacial spasm non-motor and motor-related symptoms and their response to botulinum toxin therapy |
| Q44851864 | Homes' tremor is rare kind of tremor caused by lesion of rubro-spinal tract |
| Q36336471 | Huntington's disease from the patient, caregiver and physician's perspectives: three sides of the same coin? |
| Q40584312 | Hypercortisolemia in acute stroke is related to the inflammatory response |
| Q40572623 | Hyperthermia is not an independent predictor of greater mortality in patients with primary intracerebral hemorrhage. |
| Q51480051 | Hypoalbuminemia in acute ischemic stroke patients: frequency and correlates. |
| Q39686013 | II genotype of the angiotensin-converting enzyme gene increases the risk for subarachnoid hemorrhage from ruptured aneurysm |
| Q51190786 | Implementation of X-ray fluorescence microscopy for investigation of elemental abnormalities in amyotrophic lateral sclerosis. |
| Q45028159 | Improvement of motor function in early Parkinson disease by safinamide |
| Q48490824 | Incidence of pre- and poststroke dementia: cracow stroke registry |
| Q48629923 | Increase in salsolinol level in the cerebrospinal fluid of parkinsonian patients is related to dementia: advantage of a new high-performance liquid chromatography methodology |
| Q83226695 | Increased plasma fibrinogen predicts one-year mortality in patients with acute ischemic stroke |
| Q48201776 | Inducible nitric oxide production and expression of transforming growth factor-beta1 in serum and CSF after cerebral ischaemic stroke in man. |
| Q45062534 | Influence of chemical and ischemic preconditioning on cytokine expression after focal brain ischemia |
| Q44186233 | Influence of chronic Helicobacter pylori infection on ischemic cerebral stroke risk factors. |
| Q37092283 | Influence of rs1080985 single nucleotide polymorphism of the CYP2D6 gene on response to treatment with donepezil in patients with alzheimer's disease |
| Q54646275 | Interleukin 1 beta polymorphism (-511) and risk of stroke due to small vessel disease. |
| Q42718511 | Interleukin 1beta-511 C/T polymorphism and risk of aneurysmal subarachnoid haemorrhage |
| Q83630016 | Interleukin 6-174G>C polymorphism and risk of aneurysmal subarachnoid hemorrhage: case-control study and meta-analysis |
| Q53406434 | Interleukin-1 gene -511 CT polymorphism and the risk of Alzheimer's disease in a Polish population. |
| Q48124708 | Interleukin-6 and stroke: cerebral ischemia versus nonspecific factors influencing interleukin-6. |
| Q53315925 | Interleukin-6 gene (-174 C/G ) and apolipoprotein E gene polymorphisms and the risk of Alzheimer disease in a Polish population. |
| Q48491505 | Intracerebral hemorrhage triggers interleukin-6 and interleukin-10 release in blood. |
| Q39926906 | Is hypertension a risk factor of hemifacial spasm? |
| Q44401003 | Is mannitol safe for patients with intracerebral hemorrhages? Renal considerations |
| Q50276092 | Isolated tremor of the head |
| Q44055940 | LDL phenotype A and B in ischemic stroke |
| Q44583853 | LDL phenotype B and other lipid abnormalities in patients with large vessel disease and small vessel disease |
| Q52057847 | Labile products of vascular endothelium as mediators and modulators of the functions of the central nervous system. |
| Q54399686 | Lack of association between VEGF gene polymorphisms and plasma VEGF levels and sporadic AL. |
| Q43044879 | Lack of association between interleukin-1 beta polymorphism (-511) and ischaemic stroke |
| Q51014871 | Lack of association of CR1, PICALM and CLU gene polymorphisms with Alzheimer disease in a Polish population. |
| Q60120759 | Letter to the Editor |
| Q44417993 | Lipoprotein (a) in stroke patients with large and small vessel disease |
| Q80060321 | Lower serum triglyceride level is associated with increased stroke severity |
| Q42945586 | Magnetic resonance spectroscopy (HMRS) in migraine |
| Q43962138 | Mechanisms determining the occurrence of microalbuminuria in patients with acute ischemic stroke |
| Q79239806 | Microalbuminuria and blood pressure in patients with acute ischemic stroke |
| Q40565606 | Microalbuminuria and hyperthermia independently predict long-term mortality in acute ischemic stroke patients |
| Q40603285 | Microalbuminuria in cerebrovascular diseases |
| Q74411740 | Microalbuminuria in nondiabetic patients with acute ischemic stroke: prevalence, clinical correlates, and prognostic significance |
| Q77481625 | Migraine awareness, treatment, and education in Poland |
| Q61945766 | Mitochondrial transcription factor A variants and the risk of Parkinson's disease |
| Q72597525 | Nadolol in the preventive treatment of migraine |
| Q73466546 | Neurochemical changes induced by acute and chronic administration of 1,2,3,4-tetrahydroisoquinoline and salsolinol in dopaminergic structures of rat brain |
| Q33425916 | Neurological presentation of hemophagocytic lymphohistiocytosis |
| Q46946559 | Neuroprotective effect of dopamine agonists |
| Q45282823 | Neurotrophic factor expression after focal brain ischemia preceded by different preconditioning strategies |
| Q24800368 | Nosocomial infections and immunity: lesson from brain-injured patients |
| Q54372045 | Novel pathogenic mutations and copy number variations in the VPS13A gene in patients with chorea-acanthocytosis. |
| Q48216160 | Opposite effects of l-dopa and DBS-STN on saccadic eye movements in advanced Parkinson's disease |
| Q46057397 | Orthostatic tremor as a cause of dysequilibrium |
| Q53427766 | Paraoxonase 1 gene polymorphisms do not influence the response to treatment in Alzheimer's disease. |
| Q48218985 | Paraoxonase 2 gene C311S polymorphism is associated with a risk of large vessel disease stroke in a Polish population |
| Q53426837 | Paraoxonase gene polymorphism and the risk for Alzheimer's disease in the polish population. |
| Q59632217 | Paraoxonase gene polymorphisms and sporadic ALS |
| Q83185630 | Paraoxonase-1 Q192R polymorphism and risk of sporadic amyotrophic lateral sclerosis |
| Q44592253 | Patient-reported quality of life in multiple sclerosis differs between cultures and countries: a cross-sectional Austrian-German-Polish study |
| Q39432401 | Patient-selected dosing in a six-month open-label study evaluating oral sumatriptan in the acute treatment of migraine. Sumatriptan Tablets S2CM10 Study Group. |
| Q70231035 | Peripheral stimulation in the treatment of Horton's headache |
| Q41559380 | Plasma concentration of immunoreactive beta-endorphin in healthy persons during pinpoint stimulation of receptors (acupuncture) |
| Q71080670 | Plasma cortisol concentrations in patients with different circadian pain rhythm |
| Q48854979 | Plasma immunoreactive beta-endorphin and enkephalin concentration in healthy subjects before and after electroacupuncture |
| Q54660777 | Post-stroke dementia is associated with alpha(1)-antichymotrypsin polymorphism. |
| Q44417995 | Predictors for diabetic neuropathy according to applied criteria of its diagnosis |
| Q48633319 | Predictors of poststroke dementia: results of a hospital-based study in poland |
| Q42165416 | Prefrontal N-acetylaspartate and poststroke recovery: a longitudinal proton spectroscopy study. |
| Q79825558 | Profile of laryngological abnormalities in patients with amyotrophic lateral sclerosis |
| Q45740770 | Progressive multifocal leukoencephalopathy (PML) in a patient with silicosis treated previously with steroids. A report of a case with JC virus infection confirmed immunohistochemically and by electron microscopy |
| Q80666548 | Pure primary lateral sclerosis--Case reports |
| Q80559771 | Quantitative tremor measurement with the computerized analysis of spiral drawing |
| Q72837232 | Questionnaire method of evaluating the effectiveness of the treatment of pain |
| Q66724820 | Randomized phase 2 study of FcRn antagonist efgartigimod in generalized myasthenia gravis |
| Q46638171 | Reduced prefrontal N-acetylaspartate in stroke patients with apathy |
| Q53231496 | Reversible limbic encephalitis in a person with Alzheimer's disease. |
| Q54621693 | SERPINA3 polymorphism is not associated with primary intracerebral hemorrhage in a Polish population. |
| Q45301418 | Saccadic eye movements in juvenile variant of Huntington disease. |
| Q40754122 | Serial measurement of vascular endothelial growth factor and transforming growth factor-beta1 in serum of patients with acute ischemic stroke |
| Q48713784 | Serum albumin as a determinant of cortisol release in patients with acute ischemic stroke |
| Q83161218 | Serum albumin level and nosocomial pneumonia in stroke patients |
| Q47792477 | Serum albumin level as a predictor of ischemic stroke outcome |
| Q44821241 | Serum interleukin-6 predicts cortisol release in acute stroke patients. |
| Q40524803 | Serum interleukin-6 soluble receptor in relation to interleukin-6 in stroke patients |
| Q85032664 | Severe dystonic encephalopathy without hyperphenylalaninemia associated with an 18-bp deletion within the proximal GCH1 promoter |
| Q43792619 | Severity of explicit memory impairment due to Alzheimer's disease improves effectiveness of implicit learning |
| Q48377591 | Single voxel proton magnetic resonance spectroscopy in post-stroke depression |
| Q41720269 | Small volume of the posterior cranial fossa and arterial hypertension are risk factors of hemifacial spasm. |
| Q48668152 | Spiral drawing time as a measure of bradykinesia. |
| Q39813738 | Stroke attack rates and case fatality in the Krakow Stroke Registry. |
| Q72660645 | Substance P levels in the rat forebrain after apomorphine and haloperidol treatment |
| Q48933268 | Subthalamic nucleus deep brain stimulation after bilateral pallidotomy in the treatment of generalized dystonia. |
| Q48085141 | Subtypes of interictal depressive disorders according to ICD-10 in patients with epilepsy |
| Q40523190 | Suicidality and its determinants among Polish patients with epilepsy |
| Q43432541 | Temporal changes of adiponectin plasma levels in patients with acute ischemic stroke |
| Q85208013 | The AGTR1 gene A1166C polymorphism as a risk factor and outcome predictor of primary intracerebral and aneurysmal subarachnoid hemorrhages |
| Q44073318 | The C(-1562)T polymorphism of the MMP-9 gene and the risk of sporadic amyotrophic lateral sclerosis |
| Q87294878 | The Evaluation of Abnormal Voice Qualities in Patients with Amyotrophic Lateral Sclerosis |
| Q74235390 | The application of dysarthria profile tests in ALS patients for the detection of speech disturbances |
| Q80388214 | The assessment of gait disorders in patients with Parkinson's disease using the three-dimensional motion analysis system Vicon |
| Q44639641 | The current therapies for parkinson's disease. Part I: pharmacological treatment |
| Q67267017 | The depot-form of glucocorticoid decreases cortisol but not ACTH and beta-endorphin levels in human plasma |
| Q30984647 | The effect of insulin and sulodexide (Vessel Due F) on diabetic foot syndrome: pilot study in elderly patients |
| Q37399303 | The effect of the rehabilitation program on balance, gait, physical performance and trunk rotation in Parkinson's disease. |
| Q45291811 | The effects of physiotherapy with PNF concept on gait and balance of patients with Huntington's disease - pilot study. |
| Q35062165 | The heterogeneity of neuropathological changes in amyotrophic lateral sclerosis. A review of own autopsy material. |
| Q43123364 | The impact of postadmission glycemia on stroke outcome: Glucose normalisation is associated with better survival |
| Q50682382 | The incidence and risk factors of falls in Parkinson disease: prospective study. |
| Q48008893 | The influence of botulinum toxin on auditory disturbances in hemifacial spasm |
| Q87863796 | The influence of motor ability rehabilitation on temporal-spatial parameters of gait in Huntington's disease patients on the basis of a three-dimensional motion analysis system: An experimental trial |
| Q74460139 | The prognostic significance of microalbuminuria in non-diabetic acute stroke patients |
| Q47552284 | The relation between plasma α-synuclein level and clinical symptoms or signs of Parkinson's disease |
| Q44520160 | The role of serotonin in the pathophysiology of migraine |
| Q48328910 | The short metyrapone test in chronic headache patients |
| Q44206195 | The value of motor latency difference measurements between the second lumbrical muscle and second interosseous muscle in the diagnosis of carpal tunnel syndrome |
| Q59632206 | The –A162G polymorphism of the PON1 gene and the risk of sporadic amyotrophic lateral sclerosis |
| Q42694320 | Three-Dimensional Trunk and Lower Limbs Characteristics during Gait in Patients with Huntington's Disease |
| Q43727686 | Transient hyperglycemia in ischemic stroke patients |
| Q43822572 | Tremor associated with focal and segmental dystonia |
| Q50266393 | Tremor in hemifacial spasm patients |
| Q45293909 | Tremor in neurodegenerative ataxias, Huntington disease and tic disorder |
| Q49128612 | Twenty-four-hour changes of plasmatic beta-endorphine-like immunoreactivity in healthy humans |
| Q47829821 | Urine albumin excretion in acute ischaemic stroke is related to serum interleukin-6. |
| Q73216319 | Vascular thalamic syndromes--clinical and topographic analysis |
| Q49905251 | Virtual reality for upper limb rehabilitation in sub-acute and chronic stroke: a randomized controlled trial. |
| Q68946268 | [Acupuncture analgesia--its mechanisms and use] |
| Q83753988 | [Analysis of severe and threefold atypical and serious course of catatonic-paranoid psychosis] |
| Q53940345 | [Assessment of the efficacy of treatment with pimozide in patients with amyotrophic lateral sclerosis. Introductory notes]. |
| Q67217777 | [Autonomic nervous system dysfunction in Parkinson's disease evaluated by the heart rhythm variability test] |
| Q69989600 | [Beta-endorphin levels in the blood and cerebrospinal fluid in humans] |
| Q81683270 | [Carotid artery stenting with different cerebral protection systems] |
| Q80272521 | [Carpal tunnel syndrome] |
| Q73011953 | [Clinical presentations of spongiform encephalopathies in humans] |
| Q77830730 | [Cognitive impairment and cardiovascular disease risk factors. Project CASCADE Kradów. VII: Prevalence of apoprotein E isoforms in women and men at age 65-78 years of age] |
| Q77830707 | [Cognitive impairment and cardiovascular disease risk factors. Project CASCADE Kraków. I. Project to test exposure to risk factors for cardiovascular disease in the studied sample] |
| Q44317644 | [Cognitive impairment and cardiovascular disease risk factors. Project CASCADE Kraków. IV. Prevalence of cognitive impairment in relation to age, sex, education and history of myocardial infarction in men and women at age 65-78, residents of a rural |
| Q77830719 | [Cognitive impairment and cardiovascular disease risk factors. Project CASCADE Kraków. V. Disorders of higher cerebral functions in elderly people (65-78 years old)] |
| Q77830724 | [Cognitive impairment and cardiovascular disease risk factors. Project CASCADE Kraków. VI. Magnetic resonance imaging of the aging brain in elderly persons (65-78 years old)] |
| Q80246090 | [Comparison of plasma concentrations of fibrinogen in patients with ischemic stroke due to large vessel disease and small vessel disease] |
| Q72378549 | [Congenital insensitivity to pain] |
| Q71189019 | [Cough-induced headache] |
| Q81692526 | [Decreased consciousness and ocular abnormalities as the prominent signs of bilateral ischaemic stroke of the thalamus] |
| Q73793019 | [Depressive symptoms following ischemic stroke] |
| Q80272344 | [Diagnosis and assessment of diabetic nephropathy. Literature review and author's observations] |
| Q69980797 | [Diagnostico-therapeutic algorithm in the lumbosacral pain syndrome] |
| Q73549973 | [Early diagnosis of orthostatic hypotension in idopathic Parkinson's disease] |
| Q72079366 | [Evaluation of the direct analgesic effect of ministimulators] |
| Q76375456 | [First ischemic stroke in the very old: etiology, clinical course and outcome] |
| Q79900644 | [Hemostatic markers of endothelial injury in ischaemic stroke caused by large or small vessel disease] |
| Q69468841 | [Late results of Horton's headache treatment using peripheral stimulation] |
| Q68164892 | [Methods of evaluating analgesia in humans] |
| Q81359362 | [Neurofibromatosis type 2 in a child - diagnostic difficulties] |
| Q80954210 | [Neurosarcoidosis and pain] |
| Q76375458 | [Percutaneous closure of patent foramen ovale: prevention of recurrent strokes. Immediate results and one year follow-up] |
| Q78777166 | [Percutaneous endoscopic gastrostomy in amyotrophic lateral sclerosis patients with dysphagia. A preliminary report] |
| Q71311244 | [Plasma beta-endorphins under the effect of pain stimulus. Preliminary report] |
| Q46039557 | [Plasma homocysteine concentration in patients with ischaemic stroke caused by large or small vessel disease]. |
| Q80940130 | [Predictors of one-year mortality in diabetic and nondiabetic patients with ischemic stroke] |
| Q77467897 | [Prognostic significance of early CT changes in ischemic stroke patients] |
| Q50863833 | [Prognostic significance of transient hyperglycemia in acute phase of ischemic stroke]. |
| Q71188999 | [Proposal for the creation of polish "pain language"] |
| Q79961838 | [Proprioceptive neuromuscular facilitation method of therapeutic rehabilitation in the treatment of patients with Parkinson disease] |
| Q95430660 | [Psychotic disorder in the course of Systemic Lupus Erythematosus with subcortical calcifications--case report] |
| Q64917941 | [Salsolinol, 3-O-methyl-dopa and homovanillic acid in the cerebrospinal fluid of Parkinson patients] |
| Q70229032 | [The analgesic effect of interference currents in radicular pains] |
| Q68164896 | [The concept of pain in psychology and medicine] |
| Q74215153 | [The diagnosis of subclinical hepatic encephalopathy] |
| Q53210972 | [The effect of amitriptyline on the pathological crying and other pseudobulbar signs]. |
| Q79961832 | [The effect of the complex rehabilitation on posture and gait in Parkinson disease] |
| Q73277126 | [The role of statins in prevention of ischemic stroke] |
| Q79835433 | [The value of sensory latency measured on the four median innervated fingers for the diagnosis of the carpal tunnel syndrome] |
| Q80174710 | [Vascular abnormalities in patients with primary intracerebral hemorrhage] |
| Q52008494 | [Whipple's disease--a rare cause of neurological symptoms and disorders]. |
| Q79765201 | [White matter hyperintensities in a young man] |
Search more.